Afuco™ Anti-Human CLU ADCC Therapeutic Antibody (AB-16B5), ADCC Enhanced
Anti-CLU ADCC Enhanced Antibody (AB-16B5) is an ADCC enhanced antibody produced by our Afuco™ platform. This is a humanized IgG2 antibody against an EMT-inducing form of secreted clusterin (sCLU). AB-16B5 very efficiently blocks EMT and pre-clinical data indicate that animals xenografted with various carcinoma cells show an increase of response to standard of care chemotherapy as well as a reduction of invasion.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-168CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | CLU |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | ≥1 year at -20°C. If the reconstituted antibody cannot be used within two weeks, it should be aliquoted into smaller vials and stored at -20°C |